{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:50:40Z","timestamp":1777942240030,"version":"3.51.4"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>This multicenter study investigates the efficacy of <jats:sup>18<\/jats:sup>F-FDG PET\/CT in postradiotherapy (post-RT) response evaluation in salivary gland carcinoma (SGC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We retrospectively reviewed 115 SGC patients who underwent definitive or adjuvant RT followed by <jats:sup>18<\/jats:sup>F-FDG PET\/CT between 2004 and 2021. Most tumors were parotid gland malignancies (50%). The most common histological subtypes were adenoid cystic (29%) and mucoepidermoid carcinomas (18%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median follow-up was 65 months. Post-RT anatomic images (CT\/MRI) revealed complete response (CR) in 51 patients (44%). Among 53 patients with partial response or stable disease, only 17 (32%) patients experienced locoregional recurrence, with a 5-year locoregional control rate of 69%. Post-RT <jats:sup>18<\/jats:sup>F-FDG PET\/CT documented metabolic CR in 81 patients (70%). Metabolic complete responders had significantly higher 5-year locoregional control (90% vs 43%), distant metastasis\u2013free survival (80% vs 48%), progression-free survival (76% vs 24%), and overall survival rates (89% vs 42%) compared with non\u2013complete responders (all <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), as confirmed in both univariate and multivariate analyses. It identified additional viable tumors in 18 cases (16%) and facilitated salvage local therapies in 7 patients (6%). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of post-RT <jats:sup>18<\/jats:sup>F-FDG PET\/CT were 63%, 91%, 70%, 88%, and 84%, respectively, in predicting locoregional recurrence. <jats:sup>18<\/jats:sup>F-FDG PET\/CT showed significantly higher sensitivity \ufeff(88% vs 36%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.011) in tumors with pre-RT SUV<jats:sub>max<\/jats:sub> \u22657.39 compared with those with SUV<jats:sub>max<\/jats:sub> &lt;7.39.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Post-RT <jats:sup>18<\/jats:sup>F-FDG PET\/CT demonstrates high negative predictive value and specificity, with metabolic CR predicting excellent outcomes. Additionally, it exhibits higher sensitivity for high-SUV<jats:sub>max<\/jats:sub> SGC, facilitating early detection of viable tumors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000005538","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T12:00:10Z","timestamp":1730376010000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Postradiotherapy Response Assessment Using 18F-FDG PET\/CT in Salivary Gland Carcinoma\u2014A Multicenter Study"],"prefix":"10.1097","author":[{"given":"Po-Yuan","family":"Chen","sequence":"first","affiliation":[{"name":"Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai-Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Yu","family":"Lin","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Ping","family":"Chang","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology\u2013Head & Neck Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-An","family":"Lu","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-You","family":"Tsai","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao-Fen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Min","family":"Fang","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Chang Gung Memorial Hospital at Kaohsiung and Chang Gung University College of Medicine, Kaohsiung"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Lung","family":"Hsu","sequence":"additional","affiliation":[{"name":"Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney Cheng-En","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"bib1-20241031","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hed.2890080309","article-title":"Salivary neoplasms: overview of a 35-year experience with 2,807 patients","volume":"8","year":"1986","journal-title":"Head Neck Surg"},{"key":"bib2-20241031","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.oraloncology.2011.04.020","article-title":"Salivary gland carcinoma in Denmark 1990\u20132005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)","volume":"47","year":"2011","journal-title":"Oral Oncol"},{"key":"bib3-20241031","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.critrevonc.2009.10.004","article-title":"Major and minor salivary gland tumors","volume":"74","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"bib4-20241031","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/02841860600801316","article-title":"Insights into a complex group of neoplastic disease: advances in histopathologic classification and molecular pathology of salivary gland cancer","volume":"45","year":"2006","journal-title":"Acta Oncol"},{"key":"bib5-20241031","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12105-022-01420-1","article-title":"Update from the 5th edition of the World Health Organization classification of head and neck tumors: salivary glands","volume":"16","year":"2022","journal-title":"Head Neck Pathol"},{"key":"bib6-20241031","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/cncr.21083","article-title":"Radiotherapy alone or combined with surgery for salivary gland carcinoma","volume":"103","year":"2005","journal-title":"Cancer"},{"key":"bib7-20241031","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijrobp.2004.03.018","article-title":"The role of radiotherapy in the treatment of malignant salivary gland tumors","volume":"61","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib8-20241031","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(96)00464-6","article-title":"Postoperative radiotherapy for malignant tumors of the parotid gland","volume":"37","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib9-20241031","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0360-3016(01)01724-2","article-title":"Postoperative radiotherapy for malignant tumors of the submandibular gland","volume":"51","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib10-20241031","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archoto.2011.158","article-title":"Adjuvant radiation therapy for high-grade and\/or locally advanced major salivary gland tumors","volume":"137","year":"2011","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"bib11-20241031","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hed.24984","article-title":"Adjuvant therapy in major salivary gland cancers: analysis of 8580 patients in the National Cancer Database","volume":"40","year":"2018","journal-title":"Head Neck"},{"key":"bib12-20241031","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1177\/0194599817717661","article-title":"Impact of adjuvant radiotherapy for malignant salivary gland tumors","volume":"157","year":"2017","journal-title":"Otolaryngol Head Neck Surg"},{"key":"bib13-20241031","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.coms.2023.02.004","article-title":"Perineural spread of tumor in the skull base and head and neck","volume":"35","year":"2023","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"bib14-20241031","doi-asserted-by":"crossref","first-page":"109891","DOI":"10.1016\/j.radonc.2023.109891","article-title":"A multicenter retrospective analysis of patients with salivary gland carcinoma treated with postoperative radiotherapy alone or chemoradiotherapy","volume":"188","year":"2023","journal-title":"Radiother Oncol"},{"key":"bib15-20241031","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00405-009-1028-2","article-title":"Current trends in initial management of laryngeal cancer: the declining use of open surgery","volume":"266","year":"2009","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"bib16-20241031","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00405-009-1109-2","article-title":"Current trends in initial management of oropharyngeal cancer: the declining use of open surgery","volume":"266","year":"2009","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"bib17-20241031","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1748-717X-1-23","article-title":"Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes","volume":"1","year":"2006","journal-title":"Radiat Oncol"},{"key":"bib18-20241031","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11912-022-01356-3","article-title":"Minor salivary gland Cancer of the head and neck: a review of epidemiologic aspects, prognostic factors, and outcomes","volume":"25","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"bib19-20241031","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ijrobp.2006.06.050","article-title":"Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas","volume":"66","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib20-20241031","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2478\/raon-2013-0046","article-title":"Results of photon radiotherapy for unresectable salivary gland tumors: is neutron radiotherapy\u2019s local control superior?","volume":"48","year":"2014","journal-title":"Radiol Oncol"},{"key":"bib21-20241031","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/RLU.0000000000001740","article-title":"Pretreatment primary tumor SUVmax on 18F-FDG PET\/CT images predicts outcomes in patients with salivary gland carcinoma treated with definitive intensity-modulated radiation therapy","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib22-20241031","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hed.24671","article-title":"Definitive carbon-ion radiotherapy for locally advanced parotid gland carcinomas","volume":"39","year":"2017","journal-title":"Head Neck"},{"key":"bib23-20241031","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.oraloncology.2017.02.018","article-title":"New concepts of personalized therapy in salivary gland carcinomas","volume":"68","year":"2017","journal-title":"Oral Oncol"},{"key":"bib24-20241031","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1002\/cncr.27408","article-title":"Adenoid cystic carcinoma of the head and neck","volume":"118","year":"2012","journal-title":"Cancer"},{"key":"bib25-20241031","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2307\/3577740","article-title":"Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units","volume":"123","year":"1990","journal-title":"Radiat Res"},{"key":"bib26-20241031","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1088\/0031-9155\/38\/6\/001","article-title":"A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density","volume":"38","year":"1993","journal-title":"Phys Med Biol"},{"key":"bib28-20241031","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-CT surveillance versus neck dissection in advanced head and neck cancer","volume":"374","year":"2016","journal-title":"N Engl J Med"},{"key":"bib29-20241031","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/0194599815621742","article-title":"Detecting residual\/recurrent head neck squamous cell carcinomas using PET or PET\/CT: systematic review and meta-analysis","volume":"154","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"bib30-20241031","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00259-018-3978-3","article-title":"FDG-PET\/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib31-20241031","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/coa.13566","article-title":"18F-FDG PET\/CT for response evaluation of regional lymph nodes in 97 head and neck squamous cell carcinoma patients: differences in the predictive value of residual disease after radiotherapy and chemoradiotherapy","volume":"45","year":"2020","journal-title":"Clin Otolaryngol"},{"key":"bib32-20241031","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1016\/j.clon.2023.09.006","article-title":"The effects of human papillomavirus status and treatment on the positive predictive value of post-radiotherapy 18F-fluorodeoxyglucose positron emission tomography\u2013computed tomography in advanced head and neck squamous cell carcinoma","volume":"35","year":"2023","journal-title":"Clin Oncol"},{"key":"bib33-20241031","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2214\/AJR.17.18301","article-title":"Clinical practice in PET\/CT for the management of head and neck squamous cell cancer","volume":"209","year":"2017","journal-title":"Am J Roentgenol"},{"key":"bib34-20241031","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hed.25425","article-title":"Posttreatment surveillance PET\/CT for HPV-associated oropharyngeal cancer","volume":"41","year":"2019","journal-title":"Head Neck"},{"issue":"S2","key":"bib35-20241031","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1017\/S0022215116000505","article-title":"Oropharyngeal cancer: United Kingdom national multidisciplinary guidelines","volume":"130","year":"2016","journal-title":"J Laryngol Otol"},{"key":"bib36-20241031","first-page":"174","article-title":"Summary of Japanese clinical practice guidelines for head and neck cancer\u20142022 update edited by the Japan Society for Head and Neck Cancer","volume":"51","year":"2023","journal-title":"Auris Nasus Larynx"},{"key":"bib37-20241031","article-title":"NCCN Guidelines\u00ae Insights: Merkel cell carcinoma, version 1.2024","journal-title":"J Natl Compr Canc Netw"},{"key":"bib38-20241031","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1245\/s10434-007-9761-5","article-title":"Analysis of risk factors of predictive local tumor control in oral cavity cancer","volume":"15","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"bib39-20241031","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13014-016-0617-7","article-title":"Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but not overall survival in patients with salivary gland adenoid cystic carcinoma\u2014a propensity score matched study","volume":"11","year":"2016","journal-title":"Radiat Oncol"},{"key":"bib40-20241031","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New Response Evaluation Criteria In Solid Tumours: revised RECIST guideline (version 1.1)","volume":"45","year":"2009","journal-title":"Eur J Cancer"},{"issue":"suppl 1","key":"bib41-20241031","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","year":"2009","journal-title":"J Nucl Med"},{"key":"bib42-20241031","doi-asserted-by":"crossref","first-page":"27848","DOI":"10.18632\/oncotarget.8425","article-title":"Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"bib43-20241031","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1748-717X-7-215","article-title":"The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity","volume":"7","year":"2012","journal-title":"Radiat Oncol"},{"key":"bib45-20241031","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ijrobp.2008.05.004","article-title":"Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes","volume":"73","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib46-20241031","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijrobp.2009.05.002","article-title":"Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma","volume":"77","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib47-20241031","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ijrobp.2023.09.049","article-title":"Clinical and dosimetric results of proton or photon radiation therapy for large (>5 cm) hepatocellular carcinoma: a retrospective analysis","volume":"118","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib48-20241031","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2019.02.032","article-title":"Predictors of radiation-induced liver disease in Eastern and Western patients with hepatocellular carcinoma undergoing proton beam therapy","volume":"105","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib49-20241031","doi-asserted-by":"crossref","first-page":"eabl9330","DOI":"10.1126\/sciimmunol.abl9330","article-title":"ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer","volume":"7","year":"2022","journal-title":"Sci Immunol"},{"key":"bib50-20241031","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/RLU.0000000000002530","article-title":"Prognostic value of tumor heterogeneity and SUVmax of pretreatment 18F-FDG PET\/CT for salivary gland carcinoma with high-risk histology","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib51-20241031","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/RLU.0000000000002287","article-title":"Pretreatment primary tumor and nodal SUVmax values on 18F-FDG PET\/CT images predict prognosis in patients with salivary gland carcinoma","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib52-20241031","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.radonc.2010.04.028","article-title":"Diagnostic performance of response assessment FDG-PET\/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation","volume":"97","year":"2010","journal-title":"Radiother Oncol"},{"key":"bib53-20241031","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00259-019-4272-8","article-title":"Post-radiotherapy PET\/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib54-20241031","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2214\/AJR.15.15604","article-title":"FDG PET\/CT in patients with head and neck squamous cell carcinoma after primary surgical resection with or without chemoradiation therapy","volume":"206","year":"2016","journal-title":"Am J Roentgenol"},{"issue":"S1","key":"bib55-20241031","first-page":"E511","article-title":"Detection of subclinical recurrence or second primary cancer using (18) F-FDG PET\/CT in patients treated curatively for head and neck squamous cell carcinoma","volume":"38","year":"2016","journal-title":"Head Neck"},{"key":"bib56-20241031","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00259-011-1893-y","article-title":"Diagnostic performance of post-treatment FDG PET or FDG PET\/CT imaging in head and neck cancer: a systematic review and meta-analysis","volume":"38","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib57-20241031","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1749-4486.2008.01688.x","article-title":"A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy","volume":"33","year":"2008","journal-title":"Clin Otolaryngol"},{"key":"bib58-20241031","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s13244-014-0349-x","article-title":"FDG-PET\/CT pitfalls in oncological head and neck imaging","volume":"5","year":"2014","journal-title":"Insights Imaging"},{"key":"bib59-20241031","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12885-016-2147-y","article-title":"Predictive and prognostic value of PET\/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study","volume":"16","year":"2016","journal-title":"BMC Cancer"},{"key":"bib60-20241031","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MNM.0000000000000444","article-title":"The combination of 13N-ammonia and 18F-FDG whole-body PET\/CT on the same day for diagnosis of advanced prostate cancer","volume":"37","year":"2016","journal-title":"Nucl Med Commun"},{"key":"bib61-20241031","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MNM.0000000000000457","article-title":"Pairwise comparison of 18F-FDG and 18F-FCH PET\/CT in prostate cancer patients with rising PSA and known or suspected second malignancy","volume":"37","year":"2016","journal-title":"Nucl Med Commun"},{"key":"bib62-20241031","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/bjc.2013.668","article-title":"(18)F-FDG PET\/CT surveillance at 3\u20136 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma","volume":"109","year":"2013","journal-title":"Br J Cancer"},{"key":"bib63-20241031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.oraloncology.2011.09.005","article-title":"Salivary gland carcinoma in Denmark 1990\u20132005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA)","volume":"48","year":"2012","journal-title":"Oral Oncol"},{"issue":"suppl 1","key":"bib64-20241031","first-page":"E853","article-title":"Optimal timing of first posttreatment FDG PET\/CT in head and neck squamous cell carcinoma","volume":"38","year":"2016","journal-title":"Head Neck"},{"key":"bib65-20241031","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1097\/RLU.0000000000001515","article-title":"18F-FDG PET\/CT versus contrast-enhanced CT for staging and prognostic prediction in patients with salivary gland carcinomas","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib66-20241031","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2967\/jnumed.112.116053","article-title":"Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET\/CT in salivary gland carcinomas","volume":"54","year":"2013","journal-title":"J Nucl Med"},{"key":"bib67-20241031","first-page":"240","article-title":"Clinical utility of 18F-FDG PET for patients with salivary gland malignancies","volume":"48","year":"2007","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T12:00:32Z","timestamp":1730376032000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":65,"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005538","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}